DEXA=dual-energy X-ray absorptiometry.

Indication and Usage

JULUCA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for ≥6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of JULUCA. JULUCA should be taken with a meal.

Juluca is an HIV-1 Medication that is the only single-pill, 2-drug regimen with the power of dolutegravir at the core